ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	138.15	87.63	103.15	51.35	86.52	51.09
Cash & Short-Term Investments	138.15	87.63	103.15	51.35	86.52	51.09
Cash Growth	92.88%	-15.04%	100.86%	-40.65%	69.36%	-8.64%
Accounts Receivable	135.86	158.43	50	27.42	15.51	28.58
Inventory	222.1	206.47	170.24	172.91	163.28	124.72
Other Current Assets	15.06	13.99	8.03	5.33	5.1	4.34
Total Current Assets	511.17	466.51	331.41	257.01	270.4	208.73
Net Property, Plant & Equipment	71.41	71.71	63.34	63.47	68.75	58.2
Other Intangible Assets	0.63	0.63	0.46	0.5	1.01	1.73
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53
Other Long-Term Assets	78.44	81.86	89.94	4.67	4.77	4.07
Total Assets	665.18	624.24	488.68	329.18	348.46	276.25
Accounts Payable	20.52	22.52	20.22	15.66	13.23	12.43
Accrued Expenses	48.56	40.47	34.11	32.92	24.99	17.22
Current Portion of Long-Term Debt	3.28	2.81	-	-	-	-
Current Portion of Leases	1.18	1.1	1.22	1.05	0.91	0.59
Unearned Revenue	-	-	-	0.18	0.14	0.14
Other Current Liabilities	-	2.65	-	-	-	-
Total Current Liabilities	73.54	69.54	55.54	49.81	39.27	30.38
Long-Term Debt	193.58	69.33	73.65	132.28	144.33	94.87
Long-Term Leases	6.37	6.65	8.56	9.78	10.7	7.46
Other Long-Term Liabilities	1.37	1.41	1.91	2.11	2.18	2.37
Total Long-Term Liabilities	201.32	77.38	84.12	144.17	157.22	104.7
Total Liabilities	274.86	146.92	139.66	193.98	196.49	135.08
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Treasury Stock	-143.17	-32.09	-	-	-	-
Additional Paid-in Capital	649.8	671.04	657.58	641.44	629.97	553.27
Retained Earnings	-116.33	-161.65	-308.58	-506.26	-478.02	-412.11
Shareholders' Equity	390.33	477.32	349.02	135.21	151.97	141.17
Total Liabilities & Equity	665.18	624.24	488.68	329.18	348.46	276.25
Total Debt	204.41	79.89	83.43	143.11	155.94	102.92
Net Cash (Debt)	-66.25	7.75	19.72	-91.75	-69.42	-51.83
Net Cash Growth	-	-60.72%	-	-	-	-
Net Cash Per Share	-0.27	0.03	0.08	-0.41	-0.35	-0.37
Book Value	390.33	477.32	349.02	135.21	151.97	141.17
Book Value Per Share	1.60	1.95	1.43	0.60	0.77	1.01
Tangible Book Value	386.17	473.16	345.03	131.18	147.43	135.91
Tangible Book Value Per Share	1.58	1.93	1.42	0.59	0.75	0.97

SEC Filings: 10-K · 10-Q